Natural Orifice Transgastric Endoscopic Surgical Removal of the Gallbladder
NOTESchole
Clinical Outcomes Trial of Laparoscopic Assisted Transgastric Endoscopic Cholecystectomy
1 other identifier
interventional
25
1 country
1
Brief Summary
Hypothesis: Natural orifice transgastric cholecystectomy with laparoscopic assist will be feasible and have comparable complication rates as standard lap cholecystectomy. Patient benefits will include less pain and scaring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 30, 2010
CompletedFirst Posted
Study publicly available on registry
August 3, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedSeptember 3, 2019
August 1, 2019
8.4 years
July 30, 2010
August 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain
perceived pain levels and type and frequency of pain medications will be recorded in the patient's medical record.
30 days
Secondary Outcomes (1)
Perception of surgical outcome
30 days post operatively
Study Arms (1)
NOTES cholecystectomy
EXPERIMENTALInterventions
Surgical removal of the gallbladder using endoscopic instruments.
Eligibility Criteria
You may qualify if:
- Ability to undergo general anesthesia
- Age \> 18 years of age and \< 80 years of age
- Ability to give informed consent
You may not qualify if:
- Acute cholecystitis
- Body Mass Index (BMI) \> 40
- Contraindicated for esophagogastroduodenoscopy (EGD)
- Gallstones \> 2.5cm in diameter
- Gall bladder more than 15cm in length on U/S
- Presence of common duct stones
- Presence of esophageal stricture
- Altered gastric anatomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Oregon Cliniclead
- Northwestern Universitycollaborator
Study Sites (1)
Legacy health System
Portland, Oregon, 97210, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christy M Dunst, MD
The Oregon Clinic
- STUDY DIRECTOR
Angi B Gill, RN
The Oregon Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
July 30, 2010
First Posted
August 3, 2010
Study Start
May 1, 2007
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
September 3, 2019
Record last verified: 2019-08